NFKB1 and early-onset autosomal dominant Alzheimer disease: Previous studies have shown that the activation of NF‐κB and its signaling pathway in astrocytes and macrophages promote the progression of Alzheimer's disease (AD) and atherosclerosis (AS), making them potential targets for the treatment of AD and AS.30, 31